CERO THERAPEUTICS HOLDINGS, INC. Earnings Per Share Diluted

Quick Answer

CERO THERAPEUTICS HOLDINGS, INC. reported Earnings Per Share Diluted of $18.15 (loss) per share for the year ending 2024.

  • CERO THERAPEUTICS HOLDINGS, INC. showed an increase of +81.5% in Earnings Per Share Diluted from 2024 to 2024.
  • This data is from CERO THERAPEUTICS HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2023 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2023 to 2024), CERO THERAPEUTICS HOLDINGS, INC.'s Earnings Per Share Diluted has grown by 98.5%.
  • Historical annual values: Fiscal year 2024: $18.15 (loss) per share | Fiscal year 2024: $97.90 (loss) per share | Fiscal year 2023: $1,248.64 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: